Treatment.Com International Inc.

    Treatment.Com International Inc.

    CCSE:TRUE
    - -
    CAD
    - -
    - -
    Treatment.Com International Inc.
    CSE:TRUE
    (Canadian Securities Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    CAD
    - -
    - -
    - -
    - -
    - -
    - -
    0.01
    Revenue per Share
    -0.47
    -0.45
    -2.14
    -0.61
    -0.26
    -0.17
    -0.16
    Basic EPS, GAAP
    -0.08
    -0.31
    -0.97
    -0.24
    -0.05
    -0.1
    -0.09
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    0.06
    -0.1
    -0.85
    -1.5
    -0.59
    -0.21
    -0.08
    Book Value per Share
    0.05
    -0.04
    0.02
    -0.35
    -0.05
    0.02
    -0.18
    Tangible Book Value per Share
    6
    6
    6
    6
    14
    44
    54
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    1
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    -54,790.39
    -1,585.6
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    -3
    -3
    -14
    -4
    -4
    -8
    -9
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    -68,731.51
    -1,670.11
    Profit Margin (%)
    - -
    - -
    - -
    -2
    -1
    1
    -6
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    LT Debt
    - -
    - -
    - -
    -2
    -1
    1
    8
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    51
    58
    76
    Market Capitalization
    25
    20
    22

    Working Capital

    CAD

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    Total Current Assets
    1
    3
    1
    Cash, Cash Equivalents & STI
    1
    2
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    - -
    1
    7
    Payables & Accruals
    - -
    1
    2
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -536.43%
    -207.41%
    Free Cash Flow
    - -
    176.26%
    499.95%
    Net Income, GAAP
    - -
    80.38%
    102.92%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    1
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.06
    -0.04
    -0.33
    - -
    -0.26
    2024
    -0.02
    -0.07
    -0.03
    - -
    -0.17
    2025
    -0.04
    -0.04
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business